Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GelStat Sleep is an over-the-counter sleep aid product developed by GelStat Corporation. Introduced in 2010 on a test basis to evaluate market viability, the product is positioned as a dietary supplement rather than a pharmaceutical drug. It is intended to provide relief from sleep disorders and associated symptoms, particularly insomnia. GelStat Sleep is part of a portfolio of consumer health products that includes GelStat Migraine, utilizing the company's proprietary delivery technology. While the specific active ingredients and biological targets are not publicly detailed in available clinical literature, the product is marketed as a non-prescription solution for sleep management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GelStat Sleep.